Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $18.07 and last traded at $18.07, with a volume of 111270 shares. The stock had previously closed at $19.01.
Analyst Ratings Changes
Several research analysts have issued reports on PRVA shares. Truist Financial dropped their target price on shares of Privia Health Group from $32.00 to $28.00 and set a "buy" rating on the stock in a report on Thursday, February 29th. UBS Group decreased their price target on shares of Privia Health Group from $31.00 to $29.00 and set a "buy" rating for the company in a research report on Friday, March 1st. Jefferies Financial Group started coverage on shares of Privia Health Group in a research report on Monday, February 26th. They set a "buy" rating and a $25.00 price target for the company. Bank of America lowered shares of Privia Health Group from a "buy" rating to a "neutral" rating and decreased their price target for the company from $27.00 to $21.00 in a research report on Thursday, February 22nd. Finally, TD Cowen decreased their price target on shares of Privia Health Group from $30.00 to $26.00 and set an "outperform" rating for the company in a research report on Friday, March 1st. Two equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $28.58.
View Our Latest Research Report on PRVA
Privia Health Group Stock Performance
The business's 50 day moving average price is $20.85 and its 200 day moving average price is $21.81. The firm has a market cap of $2.15 billion, a price-to-earnings ratio of 94.00, a PEG ratio of 2.68 and a beta of 0.81.
Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its quarterly earnings results on Tuesday, February 27th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.04 by ($0.02). Privia Health Group had a net margin of 1.39% and a return on equity of 3.97%. The company had revenue of $440.80 million during the quarter, compared to analyst estimates of $425.81 million. During the same period in the prior year, the business posted $0.14 EPS. Privia Health Group's revenue was up 21.0% compared to the same quarter last year. Sell-side analysts anticipate that Privia Health Group, Inc. will post 0.26 earnings per share for the current fiscal year.
Insider Activity at Privia Health Group
In other Privia Health Group news, Director William M. Sullivan sold 9,951 shares of Privia Health Group stock in a transaction on Wednesday, January 24th. The shares were sold at an average price of $23.03, for a total transaction of $229,171.53. Following the sale, the director now owns 5,464,533 shares of the company's stock, valued at approximately $125,848,194.99. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 44.80% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of the company. BlackRock Inc. boosted its position in shares of Privia Health Group by 201.7% during the 2nd quarter. BlackRock Inc. now owns 13,938,867 shares of the company's stock valued at $363,944,000 after acquiring an additional 9,319,052 shares during the last quarter. Vanguard Group Inc. boosted its position in shares of Privia Health Group by 2.5% during the 4th quarter. Vanguard Group Inc. now owns 11,278,334 shares of the company's stock valued at $259,740,000 after acquiring an additional 274,345 shares during the last quarter. Durable Capital Partners LP acquired a new position in shares of Privia Health Group during the 2nd quarter valued at about $237,364,000. Wellington Management Group LLP boosted its position in shares of Privia Health Group by 1.0% during the 3rd quarter. Wellington Management Group LLP now owns 4,656,685 shares of the company's stock valued at $107,104,000 after acquiring an additional 45,639 shares during the last quarter. Finally, Riverbridge Partners LLC boosted its position in shares of Privia Health Group by 8.2% during the 4th quarter. Riverbridge Partners LLC now owns 4,595,358 shares of the company's stock valued at $105,831,000 after acquiring an additional 348,328 shares during the last quarter. Institutional investors and hedge funds own 94.48% of the company's stock.
About Privia Health Group
(
Get Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Read More
Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
